(A) Providing sustained support for private 
sector translation and commercialization of 
products that are produced with biotechnology, 
including biomanufacturing. 
(B) Utilizing existing Federal programs, 
such as the Small Business Innovation Re-
search Program and the Small Business Tech-
nology Transfer Program (as described in sec-
tion 9 of the Small Business Act (15 U.S.C. 
638)), in support of biotechnology, including to 
support proof of concept activities, and the for-
mation of startup companies. 
(C) Accelerating the translation, scale-up, 
and commercialization of new products, proc-
esses, and technologies in order to transfer fun-
damental research results to industry and accel-
erate commercial applications. 
(D) Facilitating public-private partnerships 
in biotechnology research and development that 
address and reduce barriers to scaling up bio-
technology innovations. 
(E) Supporting a national network of 
testbeds based on open standards, interfaces, 
and processes, including by repurposing existing 
VerDate Sep 11 2014 
02:08 Apr 24, 2025
Jkt 059200
PO 00000
Frm 00034
Fmt 6652
Sfmt 6201
E:\BILLS\H2756.IH
H2756
kjohnson on DSK7ZCZBW3PROD with $$_JOB
facilities, to enable scale-up of biotechnology re-
search. 
(F) Providing incentives for retooling of in-
dustrial sites across the United States to foster 
a pivot to biotechnology. 
(G) Providing access to user facilities with 
advanced or unique equipment, services, mate-
rials, and other resources, including secure ac-
cess to high-performance computing, as appro-
priate, to industry, institutions of higher edu-
cation, nonprofit organizations, and government 
agencies to perform research and testing. 
(6) REGULATORY
STREAMLINING.—Activities 
relating to regulatory streamlining as follows: 
(A) Conducting and coordinating regu-
latory streamlining for products that are pro-
duced with biotechnology. 
(B) Easing regulatory burden for types of 
biotechnology products that have become well- 
understood by regulators, including products 
that could have occurred naturally or been de-
veloped with conventional means. 
(C) Establishing clear regulatory pathways 
for biotechnology products, including through 
VerDate Sep 11 2014 
02:08 Apr 24, 2025
Jkt 059200
PO 00000
Frm 00035
Fmt 6652
Sfmt 6201
E:\BILLS\H2756.IH
H2756
kjohnson on DSK7ZCZBW3PROD with $$_JOB
short-term regulatory trials to establish new or 
update existing regulatory pathways. 
(D) 
Ensuring 
consistent, 
risk-propor-
tionate regulation of biotechnology research and 
development activities, including for release of 
products or organisms into the environment. 
(E) Conducting horizon scanning to iden-
tify novel biotechnology products and develop 
clear regulatory pathways for such products. 
(7) BIOSAFETY AND BIOSECURITY.—Activities 
relating to biosafety and biosecurity as follows: 
(A) Addressing biosafety, biosecurity, and 
responsible 
biology 
issues 
associated 
with 
emerging biotechnology. 
(B) Developing an applied management 
plan to address biological risks of biotechnology 
research. 
(C) Creating an adaptable, evidence-based 
framework to respond to emerging biosecurity 
challenges that considers and informs updates 
of existing biosecurity governance policies, guid-
ance, and directives and identifies necessary 
safeguards for new products, processes, and 
systems of biotechnology. 
VerDate Sep 11 2014 
02:08 Apr 24, 2025
Jkt 059200
PO 00000
Frm 00036
Fmt 6652
Sfmt 6201
E:\BILLS\H2756.IH
H2756
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(D) Conducting outreach to industry, insti-
tutions of higher education, nonprofit organiza-
tions, and government agencies to increase 
awareness of biosafety and biosecurity implica-
tions of biotechnology research. 
(8) WORKFORCE DEVELOPMENT.—Activities re-
lating to workforce development as follows: 
(A) Providing sustained support for devel-
opment of a domestic biotechnology workforce. 
(B) Ensuring that Congress and Federal 
departments and agencies have access to nec-
essary expertise across national security and 
emerging biotechnology issues. 
(C) Supporting Federal biotechnology edu-
cation and workforce training programs and ini-
tiatives for students and workers. 
(D) Supporting education and training of 
undergraduate and graduate students in bio-
technology, including biomanufacturing, bio-
process engineering, and computational science 
applied to biotechnology. 
(E) Connecting researchers, graduate stu-
dents, and postdoctoral fellows with entrepre-
neurship education and training opportunities, 
including to award grants, on a competitive 
VerDate Sep 11 2014 
02:08 Apr 24, 2025
Jkt 059200
PO 00000
Frm 00037
Fmt 6652
Sfmt 6201
E:\BILLS\H2756.IH
H2756
kjohnson on DSK7ZCZBW3PROD with $$_JOB
basis, that enable institutions to support grad-
uate students, and postdoctoral fellows who per-
form some of their biotechnology research in an 
industry setting. 
(F) Supporting professional development, 
continuing education, and skills development 
(such as re-skilling and upskilling) for veterans, 
industry workers, and technology professionals. 
(G) Supporting curriculum development 
and research experiences for secondary, under-
graduate, and graduate students in bio-
technology, including through support for grad-
uate fellowships and traineeships in bio-
technology to ensure that students are receiving 
up-to-date training that keeps pace with bio-
technologies as they evolve and meets industry 
workforce needs so students are qualified for 
employment. 
(H) Supporting curriculum development 
and research experiences in biotechnology and 
associated data and information sciences across 
the Federal workforce, including for the mili-
tary education system. 
(9) BIOLITERACY.—Activities relating to biolit-
eracy as follows: 
VerDate Sep 11 2014 
02:08 Apr 24, 2025
Jkt 059200
PO 00000
Frm 00038
Fmt 6652
Sfmt 6201
E:\BILLS\H2756.IH
H2756
kjohnson on DSK7ZCZBW3PROD with $$_JOB